I was in first SA Covid-19 vaccine trial and I still feel fine
2,100 South Africans took part in a global clinical Ox1Cov-19 trial five months ago. We spoke to one of them
Nearly five months after becoming one of the first South Africans to receive a potential Covid-19 vaccine, Junior Mhlongo says he is in good health.
Mhlongo is one of 2,100 South Africans from across Gauteng who took part in a global clinical Ox1Cov-19 Vaccine VIDA Trial.
Patients were injected with a non-replicating version of a common cold virus (adenovirus) - that is unrelated to Covid 19 — and which has been engineered to include the spike protein gene, which stimulates antibody production against the SARS-CoV2 that causes Covid-19...